Intra-Cellular Therapies
#2002
Rank
$7.77B
Marketcap
United States
Country
Dr. Sharon Mates Ph.D. (Co-Founder, Chairman, CEO & Pres)
Mr. Lawrence J. Hineline CPA, CPA (Sr. VP of Fin., CFO, Treasurer & Assistant Sec.)
Mr. Michael I. Halstead J.D. (Exec. VP, Gen. Counsel & Sec.)
Summary
History
Intra-Cellular Therapies, Inc. (ICT) was founded in 2003 by Dr. Paul Greengard with a team of leading scientific researchers from Rockefeller University, targeting diseases of the central nervous system (CNS). The company is focused on transforming the lives of patients to whom existing therapies for cognition and movement disorders have had limited impact. In the years since, ICT has established a sustained portfolio of clinical and preclinical programs directed at a number of CNS indications, encompassing psychiatry, neurology and orphan diseases.
Mission
Vision
Key Team
Dr. Suresh K. Durgam M.D. (Exec. VP & Chief Medical Officer)
Mr. Mark Neumann (EVP & Chief Commercial Officer)
Ms. Karen Patruno Sheehy Esq. (Sr. VP & Chief Compliance Officer)
Dr. Robert E. Davis Ph.D. (Sr. VP & Chief Scientific Officer)
Dr. Michael Olchaskey (Sr. VP & Head of Regulatory Affairs)
Mr. Juan Fernando Sanchez (VP of Corp. Communications & Investor Relations)
Mr. John A. Bardi (Sr. VP of Market Access, Policy & Gov. Affairs)
Recognition and Awards
References
Dr. Sharon Mates Ph.D. (Co-Founder, Chairman, CEO & Pres)
Mr. Lawrence J. Hineline CPA, CPA (Sr. VP of Fin., CFO, Treasurer & Assistant Sec.)
Mr. Michael I. Halstead J.D. (Exec. VP, Gen. Counsel & Sec.)